F. Lang

发表

UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer – a retrospective analysis

W. Scheithauer, G. Kornek, D. Depisch, 2007, Anti-cancer drugs.

Randomized Phase II Study of Irinotecan Plus Mitomycin C vs. Oxaliplatin Plus Mitomycin C in Patients with Advanced Fluoropyrimidine/Leucovorin-Pretreated Colorectal Cancer

W. Scheithauer, M. Raderer, G. Kornek, 2002, Cancer investigation.

Effective Combination Chemotherapy with Bimonthly Docetaxel and Cisplatin with or without Hematopoietic Growth Factor Support in Patients with Advanced Gastroesophageal Cancer

W. Scheithauer, K. Schmid, M. Raderer, 2003, Oncology.

Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer

W. Scheithauer, B. Schneeweiss, M. Raderer, 2002, British Journal of Cancer.

Limited Value of CA 19-9 in Predicting Early Treatment Failure in Patients with Advanced Pancreatic Cancer

W. Scheithauer, F. Laengle, G. Kornek, 2008, Oncology.

Two Consecutive Phase II Studies of 5-Fluorouracil/Leucovorin/Mitomycin C and of Gemcitabine in Patients with Advanced Biliary Cancer

W. Scheithauer, T. Brodowicz, M. Raderer, 1999, Oncology.

Effective treatment of advanced breast cancer with vinorelbine, 5-fluorouracil and l-leucovorin plus human granulocyte colony-stimulating factor.

W. Scheithauer, W. Kwasny, M. Raderer, 1998, British Journal of Cancer.

Side effects during chemotherapy predict tumour response in advanced colorectal cancer

W. Scheithauer, T. Gruenberger, B. Schneeweiss, 2005, British Journal of Cancer.

Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial.

W. Scheithauer, T. Gruenberger, F. Laengle, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor

W. Scheithauer, W. Kwasny, G. Kornek, 2000, Breast Cancer Research and Treatment.

Second-Line Treatment of Advanced Gastric Cancer with Oxaliplatin plus Raltitrexed

W. Scheithauer, K. Schmid, M. Raderer, 2003, Oncology Research and Treatment.

Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial.

W. Scheithauer, B. Schneeweiss, K. Schmid, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor.

W. Scheithauer, W. Kwasny, M. Raderer, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer.

W. Scheithauer, B. Schneeweiss, K. Schmid, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma

W. Scheithauer, B. Schneeweiss, K. Schmid, 2003, British Journal of Cancer.

Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy.

W. Scheithauer, B. Schneeweiss, M. Raderer, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony‐stimulating factor

W. Scheithauer, W. Kwasny, G. Kornek, 1999, Breast Cancer Research and Treatment.

Treatment of advanced breast cancer with vinorelbine and docetaxel with or without human granulocyte colony-stimulating factor.

W. Scheithauer, B. Schneeweiss, W. Kwasny, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment o f A dvanced B reast C ancer w ith V inorelbine a nd Docetaxel W ith o r W ithout H uman G ranulocyte Colony-Stimulati ng F actor

W. Scheithauer, B. Schneeweiss, W. Kwasny, 2001 .

Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer

W. Scheithauer, W. Kwasny, G. Kornek, 2007, Acta oncologica.

Randomized multicenter phase II trial of oxaliplatin plus irinotecan versus raltitrexed as first-line treatment in advanced colorectal cancer.

W. Scheithauer, B. Schneeweiss, M. Raderer, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized M ulticenter P hase I I T rial o f T wo D ifferent Schedules o f C apecitabine P lus O xaliplatin a s F irst-Line Treatment i n A dvanced C olorectal C ancer

W. Scheithauer, B. Schneeweiss, K. Schmid, 2003 .

Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy.

W. Scheithauer, M. Raderer, G. Kornek, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma

W. Scheithauer, M. Raderer, G. Kornek, 1999, British Journal of Cancer.

R andomized M ulticenter P hase I I T rial o f O xaliplatin P lus Irinotecan V ersus R altitrexed a s F irst-Line T reatment i n Advanced C olorectal C ancer

W. Scheithauer, B. Schneeweiss, M. Raderer, 2002 .

Randomized phase II study of CPT-11 plus mitomycin C versus oxaliplatin plus mitomycin C in previously treated patients with advanced colorectal cancer (ACC)

W. Scheithauer, W. Kwasny, G. Kornek, 1999 .